Christopher J Twomey insider trades

Open-market stock purchases and sales by Christopher J Twomey, Director at Tandem Diabetes Care Inc, from SEC Form 4 filings since Jun 3, 2010.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -81%.

Recent trades

DateStockTradeValue
May 21, 2026TNDM Tandem Diabetes Care IncBought (not open market)—
May 20, 2026TNDM Tandem Diabetes Care IncBought (not open market)—
May 14, 2026BNGO Bionano Genomics, IncBought (not open market)—

Companies traded

  • TNDM Tandem Diabetes Care Inc: 2 buys, 21 sales, last May 21, 2026
  • BNGO Bionano Genomics, Inc: 1 buy, last May 14, 2026
  • SNMX Senomyx Inc: other filings, last Nov 2, 2018
  • CADX Cadence Pharmaceuticals Inc: other filings, last Mar 19, 2014

Get free alerts when Christopher J Twomey files a new trade →